Dr Lal PathLabs has enhanced its genomic capabilities by acquiring Illumina's NovaSeq X Series to the dedicated genomics division Genevolve. This additional technology expands the lab's ability to provide rapid and reliable genomic information for...
The Department of Pharmaceuticals will be supporting the research and innovation in pharma and medical technology, as the department has released an online portal for a scheme of Rs.5,000 crore. India is one of the major pharmaceutical m...
India’s pharmaceutical sector is seeing early benefits, as global drugmakers begin to shift a portion of their outsourcing arrangements from China to Indian firms, following the China+1 strategy. Major Contract Research and Manufacturing...
CuraTeQ Biologics, a wholly owned step-down subsidiary of Aurobindo Pharma, has received marketing authorization for its biosimilar Dyrupeg from the UK Medicines and Healthcare products Regulatory Agency (MHRA). The approval is an important...
The Serum Institute of India (SII), the world's leading vaccine manufacturer by volume, launched Cervavac, India’s first indigenously manufactured gender-neutral quadrivalent HPV vaccine...
In a major milestone in equitable cancer treatment, Biocon Biologics partnered with the National Cancer Society of Malaysia (NCSM) to put into action a Patient Assistance Programme (PAP) in order to increase access to affordable, quality...
A major step in the direction of infectious disease research in India, Pune-based National Institute of Virology (NIV), under the Indian Council of Medical Research (ICMR), has found anti-viral drug Favipiravir as a potential candidate against Chandi
In a significant milestone for the evolution of cancer care in India, Glenmark Pharmaceuticals announced the launch of Tevimbra (tislelizumab), an innovative immune-oncology drug of the Central Drugs Standard Control Organization (CDSCO)...
The U.S. Food and Drug Administration (FDA) approved Datroway (datopotamab deruxtecan-dlnk), an innovative TROP2-directed antibody-drug conjugate by AstraZeneca and Daiichi Sankyo, with accelerated approval. The indication is that this is applic...
Merck, known as MSD outside the U.S. and Canada, has announced positive topline results from its Phase 3 HYPERION study evaluating WINREVAIR (sotatercept-csrk)
, CDSCO.jpg)
